In 2024, Aarti Pharmalabs completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Aarti Pharmalabs has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Aarti Pharmalabs’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions of Aarti Pharmalabs amounted to 183,865.78 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Aarti Pharmalabs increased by 56.97%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2024, the total Scope 1 emissions of Aarti Pharmalabs were 88,101.32 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2023), Aarti Pharmalabs's Scope 1 emissions increased by 135.63%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
In 2024, Aarti Pharmalabs reported Scope 2 greenhouse gas (GHG) emissions of 95,764.46 tCO₂e without specifying the calculation method. a
Compared to the previous year (2023), Aarti Pharmalabs's Scope 2 emissions (Unspecified Calculation Method) rose by 20.09% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
In 2024, Aarti Pharmalabs reported its Scope 2 emissions using an unspecified methodology. a
In 2024, Aarti Pharmalabs reported Scope 1 greenhouse gas (GHG) emissions of 88,101.32 tCO₂e and total revenues of USD 218 millions. This translates into an emissions intensity of 404.68 tCO₂e per millions USD. a
In 2024, Aarti Pharmalabs reported a Scope 1 emissions intensity of 404.68 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
In 2024, Aarti Pharmalabs ranked 24 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Aarti Pharmalabs among the least efficient performers, with one of the highest emissions intensities in its sector. a